A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.

Eun Kyung Cho; Woon Ki Lee; Seok-Ah Im; Soon Nam Lee; Se Hoon Park; Soo-Mee Bang; Dong Kyun Park; Yeon Ho Park; Dong Bok Shin; Jae Hoon Lee

doi:10.1159/000086972

A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.

Identifier:nobleid.org/w1/20260515/EB0C98B8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB0C98B8.svg?ark=w1%2F20260515%2FEB0C98B8)](https://nobleid.org/work/w1/20260515/EB0C98B8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.

Identifier:nobleid.org/w1/20260515/EB0C98B8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB0C98B8.svg?ark=w1%2F20260515%2FEB0C98B8)](https://nobleid.org/work/w1/20260515/EB0C98B8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work